Annotation Detail for CLEC2B
Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001262 |
Atenolol |
Atenolol results in increased expression of CLEC2B mRNA | increases expression | 19915711
|
C014347 |
decitabine |
decitabine results in decreased expression of CLEC2B mRNA | decreases expression | 19194470
|
D007501 |
Iron |
Iron deficiency results in increased expression of CLEC2B mRNA | increases expression | 20368581
|
D015735 |
Mifepristone |
Mifepristone results in increased expression of CLEC2B mRNA | increases expression | 17584828
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of CLEC2B mRNA | affects expression | 17440010
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
6.19 | 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
3.06 | 16640825 16563566 |
MESH:D000740 |
Anemia |
|
Iron |
4.72 | 16566752 16434484 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
4.99 | 16569441 17147795 17375513 17163184 17162259 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
5.19 | 16910769 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
4.72 | 16604332 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
5.99 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
3.90 | 16632123 16640825 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
2.77 | 17352947 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
5.73 | 16640825 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.54 | 18320071 19208741 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.67 | 19215824 |
MESH:D006332 |
Cardiomegaly |
|
Atenolol |
4.92 | 15969258 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
4.26 | 16640825 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
3.55 | 16604332 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
4.28 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
4.28 | 16640825 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
4.78 | 16604332 16640825 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
3.44 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
3.15 | 16506275 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.73 | 19294695 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
4.71 | 16134523 |
MESH:D005234 |
Fatty Liver |
|
Iron |
4.46 | 16640825 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
5.91 | 16604332 16640825 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.71 | 19215824 |
MESH:D006333 |
Heart Failure |
|
Atenolol |
5.02 | 20082655 |
MESH:D006432 |
Hemochromatosis |
|
Iron |
4.74 | 16604332 16574947 17255318 17053826 16640825 17236123 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
5.83 | 16604332 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
6.08 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
5.42 | 17182432 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
4.80 | 16890145 |
MESH:D015658 |
HIV Infections |
|
Iron |
3.83 | 16597321 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
6.36 | 17440010 |
MESH:D006973 |
Hypertension |
|
Atenolol |
4.40 | 19249413 11910301 11593098 14700505 12717102 15969258 15237695 15614026 15188945 15453913 12022239 14597852 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
Atenolol |
6.05 | 15237695 |
MESH:D007006 |
Hypogonadism |
|
Iron |
4.64 | 16640825 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
5.57 | 16640825 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.42 | 17581917 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
5.44 | 17163184 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.22 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.37 | 19117987 18454857 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.42 | 19010910 17679729 18460780 18704418 18206229 19387464 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
6.07 | 18055864 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
5.91 | 16563566 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
3.90 | 16640825 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
5.49 | 16737972 17207112 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
3.24 | 20302851 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
2.67 | 16640825 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.66 | 19470736 |
MESH:D008268 |
Macular Degeneration |
|
Iron |
4.15 | 16640825 |
MESH:D008382 |
Marfan Syndrome |
|
Atenolol |
6.73 | 19430350 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.28 | 16505122 17785578 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.59 | 18172295 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
6.28 | 17086897 |
MESH:D009181 |
Mycoses |
|
Iron |
6.08 | 16640825 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.56 | 19157545 18608210 19010910 16882708 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
4.73 | 16604332 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
4.54 | 16604332 |
MESH:D009369 |
Neoplasms |
|
decitabine |
2.86 | 19470736 19116145 17925555 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
4.84 | 17178036 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
4.55 | 16604332 17296847 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
4.16 | 16640825 |
MESH:D010024 |
Osteoporosis |
|
Iron |
4.06 | 16640825 16648989 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
5.55 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
5.55 | 16525653 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.86 | 19294695 |
MESH:D010212 |
Papilloma |
|
Iron |
4.97 | 12065085 |
MESH:D020447 |
Parasomnias |
|
Iron |
6.63 | 17352947 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
3.42 | 16563566 16640825 |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
6.28 | 16604332 |
MESH:D011041 |
Poisoning |
|
Iron |
4.69 | 16604332 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
5.42 | 16640825 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
4.70 | 16640825 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
5.21 | 17616702 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
6.63 | 16640825 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
4.81 | 16930377 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.81 | 19155313 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
3.61 | 12065085 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
5.99 | 16640825 |
MESH:D018382 |
Thyroid Hormone Resistance Syndrome |
|
Atenolol |
6.87 | 9349583 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.60 | 17967635 |
MESH:D014376 |
Tuberculosis |
|
Iron |
4.29 | 16597321 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
2.83 | 17616700 19087683 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.52 | 17785578 |
PharmGKB Accession:PA26582
Releated disease ID |
Related disease Name |
PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |